They can regulate key pathways in PDAC progressions, such as apoptosis, TP53, and DNA damage, and also regulate many genes involved in suppressing p53 and DNA damage response pathways important for this common metastatic disease progression. The gene discussed is TP53; the disease is metastatic neoplasm.